Monopar Therapeutics (MNPR) Q3 2023 Earnings

Nov 9Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.22
-0.19
-0.17
-0.14

Details

Expected EPS
-0.17
Actual EPS
-0.14
Surprise EPS
0.03
Surprise Percent
+17.65%

Description

⁨Monopar Therapeutics⁩ (⁦MNPR⁩) has reported earnings of ⁦-0.14⁩ per share for ⁦Q3 2023⁩.

0 Comments

Share your thoughts